These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 27449574)

  • 1. Transporter effects on cell permeability in drug delivery.
    Mandal A; Agrahari V; Khurana V; Pal D; Mitra AK
    Expert Opin Drug Deliv; 2017 Mar; 14(3):385-401. PubMed ID: 27449574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal drug transporters: an overview.
    Estudante M; Morais JG; Soveral G; Benet LZ
    Adv Drug Deliv Rev; 2013 Oct; 65(10):1340-56. PubMed ID: 23041352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting intestinal transporters for optimizing oral drug absorption.
    Varma MV; Ambler CM; Ullah M; Rotter CJ; Sun H; Litchfield J; Fenner KS; El-Kattan AF
    Curr Drug Metab; 2010 Nov; 11(9):730-42. PubMed ID: 21189135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transport mechanisms at the pulmonary mucosa: implications for drug delivery.
    Nickel S; Clerkin CG; Selo MA; Ehrhardt C
    Expert Opin Drug Deliv; 2016; 13(5):667-90. PubMed ID: 26909544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of Drug or Food with Drug Transporters in Intestine and Liver.
    Nakanishi T; Tamai I
    Curr Drug Metab; 2015; 16(9):753-64. PubMed ID: 26630906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the understanding of retinal drug disposition and the role of blood-ocular barrier transporters.
    Jordán J; Ruíz-Moreno JM
    Expert Opin Drug Metab Toxicol; 2013 Sep; 9(9):1181-92. PubMed ID: 23647131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression, activity and pharmacokinetic impact of ocular transporters.
    Vellonen KS; Hellinen L; Mannermaa E; Ruponen M; Urtti A; Kidron H
    Adv Drug Deliv Rev; 2018 Feb; 126():3-22. PubMed ID: 29248478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efflux and uptake transporters involved in the disposition of bazedoxifene.
    Lušin TT; Mrhar A; Stieger B; Kristl A; Berginc K; Trontelj J
    Eur J Drug Metab Pharmacokinet; 2016 Jun; 41(3):251-7. PubMed ID: 25631963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted prodrugs in oral drug delivery: the modern molecular biopharmaceutical approach.
    Dahan A; Khamis M; Agbaria R; Karaman R
    Expert Opin Drug Deliv; 2012 Aug; 9(8):1001-13. PubMed ID: 22703376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hurdles with using in vitro models to predict human blood-brain barrier drug permeability: a special focus on transporters and metabolizing enzymes.
    Shawahna R; Decleves X; Scherrmann JM
    Curr Drug Metab; 2013 Jan; 14(1):120-36. PubMed ID: 23215812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transporter-mediated drug delivery: recent progress and experimental approaches.
    Sai Y; Tsuji A
    Drug Discov Today; 2004 Aug; 9(16):712-20. PubMed ID: 15341785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereoselectivity of chiral drug transport: a focus on enantiomer-transporter interaction.
    Zhou Q; Yu LS; Zeng S
    Drug Metab Rev; 2014 Aug; 46(3):283-90. PubMed ID: 24796860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of nuclear receptors in the regulation of drug transporters in the brain.
    Chan GN; Hoque MT; Bendayan R
    Trends Pharmacol Sci; 2013 Jul; 34(7):361-72. PubMed ID: 23769624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantifying the impact of transporters on cellular drug permeability.
    Matsson P; Fenu LA; Lundquist P; Wiśniewski JR; Kansy M; Artursson P
    Trends Pharmacol Sci; 2015 May; 36(5):255-62. PubMed ID: 25799456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo approaches to characterize transporter-mediated disposition in drug discovery.
    Feng B; Varma MV; Costales C; Zhang H; Tremaine L
    Expert Opin Drug Discov; 2014 Aug; 9(8):873-90. PubMed ID: 24857286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transporter assays as useful in vitro tools in drug discovery and development.
    Volpe DA
    Expert Opin Drug Discov; 2016; 11(1):91-103. PubMed ID: 26512742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transporters and drug-drug interactions: important determinants of drug disposition and effects.
    König J; Müller F; Fromm MF
    Pharmacol Rev; 2013 Jul; 65(3):944-66. PubMed ID: 23686349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal absorption mechanism of mirabegron, a potent and selective β₃-adrenoceptor agonist: involvement of human efflux and/or influx transport systems.
    Takusagawa S; Ushigome F; Nemoto H; Takahashi Y; Li Q; Kerbusch V; Miyashita A; Iwatsubo T; Usui T
    Mol Pharm; 2013 May; 10(5):1783-94. PubMed ID: 23560393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence-based approach to assess passive diffusion and carrier-mediated drug transport.
    Di L; Artursson P; Avdeef A; Ecker GF; Faller B; Fischer H; Houston JB; Kansy M; Kerns EH; Krämer SD; Lennernäs H; Sugano K
    Drug Discov Today; 2012 Aug; 17(15-16):905-12. PubMed ID: 22507594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interplay of Drug-Metabolizing Enzymes and Transporters in Drug Absorption and Disposition.
    Shi S; Li Y
    Curr Drug Metab; 2014; 15(10):915-41. PubMed ID: 25828591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.